Annual FCF
-$415.75 M
-$104.90 M-33.75%
31 December 2023
Summary:
Cytokinetics Incorporated annual free cash flow is currently -$415.75 million, with the most recent change of -$104.90 million (-33.75%) on 31 December 2023. During the last 3 years, it has fallen by -$413.64 million (-19613.09%). CYTK annual FCF is now -1274.90% below its all-time high of $35.39 million, reached on 31 December 2016.CYTK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$102.20 M
-$973.00 K-0.96%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly free cash flow is currently -$102.20 million, with the most recent change of -$973.00 thousand (-0.96%) on 30 September 2024. Over the past year, it has dropped by -$5.78 million (-5.99%). CYTK quarterly FCF is now -232.77% below its all-time high of $76.97 million, reached on 31 December 2016.CYTK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$407.05 M
-$5.78 M-1.44%
30 September 2024
Summary:
Cytokinetics Incorporated TTM free cash flow is currently -$407.05 million, with the most recent change of -$5.78 million (-1.44%) on 30 September 2024. Over the past year, it has increased by +$35.98 million (+8.12%). CYTK TTM FCF is now -1250.31% below its all-time high of $35.39 million, reached on 31 December 2016.CYTK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.8% | -6.0% | +8.1% |
| 3 y3 years | -10000.0% | -87.6% | -388.6% |
| 5 y5 years | -307.2% | -380.4% | -375.0% |
CYTK Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -268.3% | +21.1% | -388.6% | +8.1% |
| 5 y | 5 years | <-9999.0% | at low | -324.1% | +21.1% | <-9999.0% | +8.1% |
| alltime | all time | -1274.9% | at low | -232.8% | +21.1% | -1250.3% | +8.1% |
Cytokinetics Incorporated Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$102.20 M(+1.0%) | -$407.05 M(+1.4%) |
| June 2024 | - | -$101.23 M(-21.8%) | -$401.27 M(-5.0%) |
| Mar 2024 | - | -$129.51 M(+74.7%) | -$422.57 M(+1.6%) |
| Dec 2023 | -$415.75 M(+33.7%) | -$74.11 M(-23.1%) | -$415.75 M(-6.2%) |
| Sept 2023 | - | -$96.42 M(-21.3%) | -$443.03 M(+1.4%) |
| June 2023 | - | -$122.52 M(-0.1%) | -$436.98 M(+7.7%) |
| Mar 2023 | - | -$122.69 M(+21.0%) | -$405.79 M(+30.5%) |
| Dec 2022 | -$310.85 M(+62.4%) | -$101.39 M(+12.2%) | -$310.85 M(+14.3%) |
| Sept 2022 | - | -$90.37 M(-1.1%) | -$271.95 M(+15.2%) |
| June 2022 | - | -$91.33 M(+229.1%) | -$236.05 M(+29.0%) |
| Mar 2022 | - | -$27.75 M(-55.6%) | -$183.00 M(-4.4%) |
| Dec 2021 | -$191.39 M(+8975.1%) | -$62.49 M(+14.7%) | -$191.39 M(+129.7%) |
| Sept 2021 | - | -$54.47 M(+42.3%) | -$83.31 M(+388.2%) |
| June 2021 | - | -$38.29 M(+5.9%) | -$17.06 M(+141.1%) |
| Mar 2021 | - | -$36.15 M(-179.3%) | -$7.08 M(+235.6%) |
| Dec 2020 | -$2.11 M(-97.7%) | $45.59 M(+287.2%) | -$2.11 M(-96.9%) |
| Sept 2020 | - | $11.78 M(-141.6%) | -$68.06 M(-32.7%) |
| June 2020 | - | -$28.30 M(-9.2%) | -$101.11 M(+3.7%) |
| Mar 2020 | - | -$31.18 M(+53.1%) | -$97.54 M(+4.3%) |
| Dec 2019 | -$93.53 M(-8.4%) | -$20.36 M(-4.3%) | -$93.53 M(+9.1%) |
| Sept 2019 | - | -$21.27 M(-14.0%) | -$85.70 M(-11.7%) |
| June 2019 | - | -$24.73 M(-9.0%) | -$97.02 M(-2.2%) |
| Mar 2019 | - | -$27.16 M(+116.7%) | -$99.20 M(-2.8%) |
| Dec 2018 | -$102.10 M(-2.4%) | -$12.54 M(-61.5%) | -$102.10 M(-10.8%) |
| Sept 2018 | - | -$32.59 M(+21.1%) | -$114.42 M(+6.2%) |
| June 2018 | - | -$26.91 M(-10.5%) | -$107.76 M(-4.1%) |
| Mar 2018 | - | -$30.07 M(+21.0%) | -$112.37 M(+7.4%) |
| Dec 2017 | -$104.64 M(-395.7%) | -$24.85 M(-4.2%) | -$104.64 M(+3623.7%) |
| Sept 2017 | - | -$25.93 M(-17.7%) | -$2.81 M(-126.3%) |
| June 2017 | - | -$31.52 M(+41.1%) | $10.70 M(-65.5%) |
| Mar 2017 | - | -$22.33 M(-129.0%) | $30.98 M(-12.4%) |
| Dec 2016 | $35.39 M(+718.9%) | $76.97 M(-719.4%) | $35.39 M(-168.4%) |
| Sept 2016 | - | -$12.43 M(+10.6%) | -$51.73 M(+4.1%) |
| June 2016 | - | -$11.23 M(-37.3%) | -$49.71 M(+3.9%) |
| Mar 2016 | - | -$17.93 M(+76.7%) | -$47.84 M(-1207.0%) |
| Dec 2015 | $4.32 M(-109.4%) | -$10.15 M(-2.4%) | $4.32 M(-29.0%) |
| Sept 2015 | - | -$10.40 M(+11.1%) | $6.09 M(-11.4%) |
| June 2015 | - | -$9.36 M(-127.4%) | $6.88 M(+6.8%) |
| Mar 2015 | - | $34.23 M(-508.6%) | $6.44 M(-114.0%) |
| Dec 2014 | -$45.95 M | -$8.38 M(-12.9%) | -$45.95 M(-8.6%) |
| Sept 2014 | - | -$9.62 M(-1.9%) | -$50.25 M(+65.3%) |
| June 2014 | - | -$9.80 M(-46.0%) | -$30.40 M(+116.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$18.16 M(+43.2%) | -$14.02 M(+69.7%) |
| Dec 2013 | -$8.26 M(-75.4%) | -$12.68 M(-223.8%) | -$8.26 M(+199.1%) |
| Sept 2013 | - | $10.24 M(+55.6%) | -$2.76 M(-87.4%) |
| June 2013 | - | $6.58 M(-153.1%) | -$21.93 M(-41.1%) |
| Mar 2013 | - | -$12.40 M(+72.6%) | -$37.21 M(+10.9%) |
| Dec 2012 | -$33.56 M(-27.1%) | -$7.18 M(-19.5%) | -$33.56 M(-10.1%) |
| Sept 2012 | - | -$8.92 M(+2.5%) | -$37.35 M(-1.2%) |
| June 2012 | - | -$8.71 M(-0.5%) | -$37.79 M(-9.4%) |
| Mar 2012 | - | -$8.75 M(-20.2%) | -$41.73 M(-9.4%) |
| Dec 2011 | -$46.04 M(+1.6%) | -$10.97 M(+17.1%) | -$46.04 M(+4.1%) |
| Sept 2011 | - | -$9.37 M(-26.0%) | -$44.25 M(-2.4%) |
| June 2011 | - | -$12.65 M(-3.1%) | -$45.33 M(-1.5%) |
| Mar 2011 | - | -$13.05 M(+42.2%) | -$46.02 M(+1.5%) |
| Dec 2010 | -$45.32 M(-676.2%) | -$9.18 M(-12.2%) | -$45.32 M(+6.1%) |
| Sept 2010 | - | -$10.45 M(-21.6%) | -$42.70 M(-2.7%) |
| June 2010 | - | -$13.33 M(+7.9%) | -$43.89 M(-684.3%) |
| Mar 2010 | - | -$12.36 M(+88.5%) | $7.51 M(-4.5%) |
| Dec 2009 | $7.87 M(-112.7%) | -$6.56 M(-43.7%) | $7.87 M(+491.0%) |
| Sept 2009 | - | -$11.64 M(-130.6%) | $1.33 M(-136.2%) |
| June 2009 | - | $38.07 M(-417.0%) | -$3.68 M(-93.8%) |
| Mar 2009 | - | -$12.01 M(-8.3%) | -$59.79 M(-3.5%) |
| Dec 2008 | -$61.99 M(+1013.3%) | -$13.09 M(-21.4%) | -$61.99 M(-2.1%) |
| Sept 2008 | - | -$16.65 M(-7.7%) | -$63.33 M(+10.8%) |
| June 2008 | - | -$18.04 M(+27.1%) | -$57.15 M(+8.1%) |
| Mar 2008 | - | -$14.20 M(-1.6%) | -$52.84 M(+849.0%) |
| Dec 2007 | -$5.57 M(-89.4%) | -$14.43 M(+37.9%) | -$5.57 M(-6.3%) |
| Sept 2007 | - | -$10.47 M(-23.8%) | -$5.94 M(-33.8%) |
| June 2007 | - | -$13.74 M(-141.5%) | -$8.97 M(+18.8%) |
| Mar 2007 | - | $33.07 M(-323.4%) | -$7.55 M(-85.6%) |
| Dec 2006 | -$52.54 M(+28.3%) | -$14.81 M(+9.7%) | -$52.54 M(+9.4%) |
| Sept 2006 | - | -$13.50 M(+9.6%) | -$48.03 M(+9.9%) |
| June 2006 | - | -$12.32 M(+3.4%) | -$43.69 M(-0.2%) |
| Mar 2006 | - | -$11.91 M(+15.7%) | -$43.79 M(+6.9%) |
| Dec 2005 | -$40.95 M(+15.6%) | -$10.30 M(+12.4%) | -$40.95 M(-4.1%) |
| Sept 2005 | - | -$9.16 M(-26.3%) | -$42.68 M(-0.6%) |
| June 2005 | - | -$12.42 M(+36.9%) | -$42.93 M(+14.9%) |
| Mar 2005 | - | -$9.07 M(-24.6%) | -$37.36 M(+5.4%) |
| Dec 2004 | -$35.43 M(+5.0%) | -$12.03 M(+28.0%) | -$35.43 M(+51.4%) |
| Sept 2004 | - | -$9.40 M(+37.3%) | -$23.40 M(+67.2%) |
| June 2004 | - | -$6.85 M(-4.2%) | -$14.00 M(+95.8%) |
| Mar 2004 | - | -$7.15 M | -$7.15 M |
| Dec 2003 | -$33.75 M(+16.9%) | - | - |
| Dec 2002 | -$28.87 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual free cash flow?
- What is the all time high annual FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual FCF year-on-year change?
- What is Cytokinetics Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly FCF year-on-year change?
- What is Cytokinetics Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM FCF year-on-year change?
What is Cytokinetics Incorporated annual free cash flow?
The current annual FCF of CYTK is -$415.75 M
What is the all time high annual FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual free cash flow is $35.39 M
What is Cytokinetics Incorporated annual FCF year-on-year change?
Over the past year, CYTK annual free cash flow has changed by -$104.90 M (-33.75%)
What is Cytokinetics Incorporated quarterly free cash flow?
The current quarterly FCF of CYTK is -$102.20 M
What is the all time high quarterly FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly free cash flow is $76.97 M
What is Cytokinetics Incorporated quarterly FCF year-on-year change?
Over the past year, CYTK quarterly free cash flow has changed by -$5.78 M (-5.99%)
What is Cytokinetics Incorporated TTM free cash flow?
The current TTM FCF of CYTK is -$407.05 M
What is the all time high TTM FCF for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM free cash flow is $35.39 M
What is Cytokinetics Incorporated TTM FCF year-on-year change?
Over the past year, CYTK TTM free cash flow has changed by +$35.98 M (+8.12%)